1Department of Otolaryngology-Head and Neck Surgery, Kitano Hospital, Tazuke
Kofukai Medical Research Institute, Japan
2Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Japan
*Corresponding Author: Toru Miwa, Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Japan.
Received: August 04, 2021; Published: October 20, 2021
Introduction: The Hospital Anxiety and Depression Scale (HADS) was developed by Zigmond and Snaith in 1983. HADS is a widely-used 14-item self-reported scale designed to briefly measure anxiety and depressive symptoms in non-psychiatric hospital patients. HADS only takes 2 to 5 minutes to complete. There are independent subscales for anxiety and depression.
Materials and Methods: We performed the HADS test on 25 balance disorder patients, and then investigated relationships between their HADS scores and their prognoses based upon their medical records. The 25 patients underwent the HADS test and an equilibrium test. We categorized positive (>12) and negative (<11) on the HADS test. We also categorized their prognoses into 4 categories: “cure”; “improved”; “unchanged”; and “deteriorated”.
Results: Thirteen patients (52%) showed positive results, and twelve patients (48%) showed negative results, on the HADS test. Seven (53.8%) of the 13 patients who demonstrated HADS test positive result showed “cure” or “improved” prognoses, while the eleven (91.7%) of the 12 patients who demonstrated HADS test negative result showed “cure” or “improved” prognoses.
Conclusions: Screening of patents with dizziness to check for depression and anxiety with the use of HADS was useful in the treatment and prognosis assessment of dizziness.
Keywords: Anxiety; Depression; HADS; Balance Disorder
Citation: Toru Miwa. “Hospital Anxiety and Depression Scale (HADS) Test for Balance Disorder Patients". Acta Scientific Medical Sciences 5.11 (2021): 106-110.
Copyright: © 2021 Toru Miwa. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.